UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 146

Sortiert nach

A Double-blind, Randomized, Placebo-controlled Study of the Efficacy and Safety of Duloxetine for the Treatment of Chronic Pain Due to Osteoarthritis of the Knee

Pain practice, 2011-01, Vol.11 (1), p.33-41

2011

Volltextzugriff (PDF)

Epidemiology, Public Health Burden, and Treatment of Diabetic Peripheral Neuropathic Pain: A Review

Pain medicine (Malden, Mass.), 2007-09, Vol.8 (s2), p.S50-S62

2007

Volltextzugriff (PDF)

BAER-101, a selective potentiator of α2- and α3-containing GABA A receptors, fully suppresses spontaneous cortical spike-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg (GAERS)

Drug development research, 2024-04, Vol.85 (2), p.e22160

2024

Volltextzugriff (PDF)

BAER‐101, a selective potentiator of α2‐ and α3‐containing GABAA receptors, fully suppresses spontaneous cortical spike‐wave discharges in Genetic Absence Epilepsy Rats from Strasbourg (GAERS)

Drug development research, 2024-04, Vol.85 (2), p.e22160-n/a

2024

Volltextzugriff (PDF)

Impact of Disease Characteristics on the Efficacy of Duloxetine in Diabetic Peripheral Neuropathic Pain

Diabetes care, 2007-03, Vol.30 (3), p.664-669

2007

Volltextzugriff (PDF)

A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia

International journal of general medicine, 2008-12, Vol.1 (default), p.91-102

2008

Volltextzugriff (PDF)

Long-Term Safety, Tolerability, and Efficacy of Duloxetine in the Treatment of Fibromyalgia

Seminars in arthritis and rheumatism, 2010-06, Vol.39 (6), p.454-464

2010

Volltextzugriff (PDF)

Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: A 13-week, randomized, placebo-controlled trial

Pain (Amsterdam), 2009-12, Vol.146 (3), p.253-260

2009

Volltextzugriff (PDF)

Toward a Lifestyle Medicine Approach to Illness Anxiety Disorder (Formerly Hypochondriasis)

American Journal of Lifestyle Medicine, 2018-09, Vol.12 (5), p.365-369

Chappell, Amy S.

2018

Volltextzugriff (PDF)

Efficacy and safety of duloxetine in patients with chronic low back pain

Spine (Philadelphia, Pa. 1976), 2010-06, Vol.35 (13), p.E578-E585

2010

Volltextzugriff (PDF)

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial

Pain (Amsterdam), 2008-06, Vol.136 (3), p.432-444

2008

Volltextzugriff (PDF)

Estimation of minimum clinically important difference for pain in fibromyalgia

Arthritis care & research (2010), 2011-06, Vol.63 (6), p.821-826

2011

Volltextzugriff (PDF)

Results from clinical trials of a selective ionotropic glutamate receptor 5 (iGluR5) antagonist, LY5454694 tosylate, in 2 chronic pain conditions

Pain (Amsterdam), 2014-06, Vol.155 (6), p.1140-1149

2014

Volltextzugriff (PDF)

Safety, tolerability, pharmacokinetics, and effects on human experimental pain of the selective ionotropic glutamate receptor 5 (iGluR5) antagonist LY545694 in healthy volunteers

Pain (Amsterdam), 2014-05, Vol.155 (5), p.929-936

2014

Volltextzugriff (PDF)

Tailoring chronic pain treatments for the elderly: are we prepared for the challenge?

Drug discovery today, 2014-01, Vol.19 (1), p.8-17

2014

Volltextzugriff (PDF)

A 1-year Safety and Efficacy Study of Duloxetine in Patients With Fibromyalgia

The Clinical journal of pain, 2009-06, Vol.25 (5), p.365-375

2009

Volltextzugriff (PDF)

Maintenance of Effect of Duloxetine in Patients with Chronic Low Back Pain: A 41-week Uncontrolled, Dose-blinded Study

Pain medicine (Malden, Mass.), 2010-05, Vol.11 (5), p.648-657

2010

Volltextzugriff (PDF)

The relationship between antidepressant and analgesic responses: findings from six placebo-controlled trials assessing the efficacy of duloxetine in patients with major depressive disorder

Current medical research and opinion, 2008-11, Vol.24 (11), p.3105-3115

2008

Volltextzugriff (PDF)

Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain

Diabetes/metabolism research and reviews, 2009-10, Vol.25 (7), p.623-631

2009

Volltextzugriff (PDF)

Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials

Clinical rheumatology, 2009-09, Vol.28 (9), p.1035-1044

2009

Volltextzugriff (PDF)

Comparisons of the Efficacy and Safety of Duloxetine for the Treatment of Fibromyalgia in Patients With Versus Without Major Depressive Disorder

The Clinical journal of pain, 2009-07, Vol.25 (6), p.461-468

2009

Volltextzugriff (PDF)

An Open-Label 52-Week Clinical Extension Comparing Duloxetine with Routine Care in Patients with Diabetic Peripheral Neuropathic Pain

Pain medicine (Malden, Mass.), 2007-09, Vol.8 (6), p.503-513

2007

Volltextzugriff (PDF)

Duloxetine for the Management of Diabetic Peripheral Neuropathic Pain: Evaluation of Functional Outcomes

Pain medicine (Malden, Mass.), 2007-07, Vol.8 (5), p.410-418

2007

Volltextzugriff (PDF)

Brain Functional Changes and Duloxetine Treatment Response in Fibromyalgia: A Pilot Study

Pain medicine (Malden, Mass.), 2009-05, Vol.10 (4), p.730-738

2009

Volltextzugriff (PDF)

Effect of duloxetine in patients with fibromyalgia: tiredness subgroups

Arthritis research & therapy, 2010-01, Vol.12 (4), p.R141-R141

2010

Volltextzugriff (PDF)

1 – 25 von 146

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(122)

Publikationsform

Sprache

Englisch
(146)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A Double-blind, Randomized, Placebo-controlled Study of the Efficacy and Safety of Duloxetine for the Treatment of Chronic Pain Due to Osteoarthritis of the Knee

Epidemiology, Public Health Burden, and Treatment of Diabetic Peripheral Neuropathic Pain: A Review

BAER-101, a selective potentiator of α2- and α3-containing GABA A receptors, fully suppresses spontaneous cortical spike-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg (GAERS)

BAER‐101, a selective potentiator of α2‐ and α3‐containing GABAA receptors, fully suppresses spontaneous cortical spike‐wave discharges in Genetic Absence Epilepsy Rats from Strasbourg (GAERS)

Impact of Disease Characteristics on the Efficacy of Duloxetine in Diabetic Peripheral Neuropathic Pain

A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia

Long-Term Safety, Tolerability, and Efficacy of Duloxetine in the Treatment of Fibromyalgia

Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: A 13-week, randomized, placebo-controlled trial

Toward a Lifestyle Medicine Approach to Illness Anxiety Disorder (Formerly Hypochondriasis)

Efficacy and safety of duloxetine in patients with chronic low back pain

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial

Estimation of minimum clinically important difference for pain in fibromyalgia

Results from clinical trials of a selective ionotropic glutamate receptor 5 (iGluR5) antagonist, LY5454694 tosylate, in 2 chronic pain conditions

Safety, tolerability, pharmacokinetics, and effects on human experimental pain of the selective ionotropic glutamate receptor 5 (iGluR5) antagonist LY545694 in healthy volunteers

Tailoring chronic pain treatments for the elderly: are we prepared for the challenge?

A 1-year Safety and Efficacy Study of Duloxetine in Patients With Fibromyalgia

Maintenance of Effect of Duloxetine in Patients with Chronic Low Back Pain: A 41-week Uncontrolled, Dose-blinded Study

The relationship between antidepressant and analgesic responses: findings from six placebo-controlled trials assessing the efficacy of duloxetine in patients with major depressive disorder

Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain

Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials

Comparisons of the Efficacy and Safety of Duloxetine for the Treatment of Fibromyalgia in Patients With Versus Without Major Depressive Disorder

An Open-Label 52-Week Clinical Extension Comparing Duloxetine with Routine Care in Patients with Diabetic Peripheral Neuropathic Pain

Duloxetine for the Management of Diabetic Peripheral Neuropathic Pain: Evaluation of Functional Outcomes

Brain Functional Changes and Duloxetine Treatment Response in Fibromyalgia: A Pilot Study

Effect of duloxetine in patients with fibromyalgia: tiredness subgroups

Suchergebnisse filtern